Wellis is a European weight loss programme operating in Dutch- and German-speaking markets, combining medication with a personalised treatment plan and support from a team of doctors and health experts. Unlike the prescribe-only European services, it sells a subscription that bundles the treatment plan with medication, and it publishes clear per-month pricing. This review evaluates Wellis across pricing, medications, eligibility, support, and competitive positioning.

Quick Takeaway:

• European weight loss programme operating in Dutch and German-language markets
• Semaglutide (Ozempic) published from €149 per month, discounted from €249
• Mounjaro (tirzepatide) published from €259 per month
• Some published entry pricing appears from €179 per month depending on plan
• Subscription model bundling a personalised treatment plan with medication, with free discreet delivery

Looking for a Better Alternative?

We benchmark every provider against the highest-rated service we track. CoreAge Rx is our top-rated favorite for GLP-1 weight loss therapy overall, combining competitive pricing with exceptional customer service, faster medication delivery, and more comprehensive support resources.

Why we recommend CoreAge Rx:

• Lower monthly costs than most competitors ($179–$399 range)
• Faster prescription approval (typically 12–24 hours)
• More extensive provider support included at no extra charge
• Better medication availability during shortages
• Higher patient satisfaction scores (4.7/5)

CoreAge Rx serves patients in the United States. For European patients, Wellis competes most directly with DoktorABC, Dokteronline, and Mobi Doctor.

New Patient Special: Save up to $200 on your first three months. Rated 4.7/5 stars by verified customers. Available to patients in the United States.

Overview: What Is Wellis?

Wellis is a European medical weight loss service operating in Dutch- and German-speaking markets. Its model is a subscription programme rather than a one-off prescription: patients complete a questionnaire to check eligibility, and a team of doctors and health experts supports them through the treatment journey with a personalised plan.

The service markets free, discreet delivery and publishes educational content in Dutch on weight loss injections — how they work, who they suit, and what they cost — covering Wegovy, Ozempic, and Mounjaro.

Its structure sits between the two dominant European models. Prescribe-only services such as Mobi Doctor leave you to source medication yourself; dispensing services such as Dokteronline sell you a prescription and the product. Wellis bundles medication into an ongoing programme with a treatment plan, which is closer to the US subscription model than most European providers.

Medications Offered

Wellis's published Dutch content describes semaglutide activating GLP-1 receptors to suppress appetite and promote weight loss, and Mounjaro stimulating both GLP-1 and GIP receptors — an accurate description of the mechanistic difference. It cites weight loss of 10–22% of body weight in reference to semaglutide trial data with 1,961 participants.

Important: Ozempic is licensed for type 2 diabetes rather than for weight management. Wegovy is the semaglutide product licensed for chronic weight management. Prescribing Ozempic for weight loss is off-label, which is legal and common but has implications for reimbursement and supply. Confirm which product you would receive and under which indication. See our alternatives to Ozempic guide.

Consultation Process and Provider Involvement

1. Complete the eligibility questionnaire. Wellis describes filling in a questionnaire to see whether you qualify.
2. Medical review. A team of doctors and health experts assesses suitability.
3. Personalised treatment plan. Wellis states it draws up a personal treatment plan aligned to your goals.
4. Subscription and delivery. Medication supplied on an ongoing subscription with free discreet delivery.
5. Ongoing support. The team supports you at each step of the journey.

Eligibility and Lab Requirements

Standard European criteria apply: generally a BMI of 30 or above, or 27 or above with a weight-related condition. Contraindications are the class standard — personal or family history of medullary thyroid carcinoma, MEN2 syndrome, pregnancy, breastfeeding, and known hypersensitivity.

As with most questionnaire-led services, routine baseline laboratory testing should not be assumed. Ask whether labs are required, and obtain them independently if you have thyroid, pancreatic, gallbladder, or diabetes history. See our eligibility guide.

Pricing

Pro Tip: Wellis publishes more than one entry figure — €149 and €179 both appear in its Dutch-language materials, alongside a €249 pre-discount reference. That usually indicates promotional pricing that resets, or different plan lengths. Ask specifically what you will be charged in month three, and whether the €149 rate is introductory or ongoing, before subscribing.

For wider European market context, our Europe GLP-1 cost guide sets out pricing across countries and providers.

Check Wellis Pricing

European weight loss programme with semaglutide from €149/month and Mounjaro from €259/month, including a personalised treatment plan and free discreet delivery.

Pharmacy Fulfilment and Shipping

Wellis advertises free, discreet delivery as part of its subscription. Injectable GLP-1s require refrigeration before first use, with defined room-temperature allowances afterwards. Because subscription models ship on a recurring schedule, make sure delivery timing matches your dosing schedule so you do not run out mid-titration — a common and avoidable problem. See our storage and shipping guide.

Support Services

• Team of doctors and health experts supporting the treatment journey
• Personalised treatment plan aligned to individual goals
• Published Dutch-language education on weight loss injections, mechanisms, and costs
• Ongoing subscription management

This is more support than a pure dispensing service provides, though Wellis does not describe a structured behavioural curriculum or a named dietitian relationship in the sense of Second Nature.

Cancellation, Refunds, Insurance, and Costs

Wellis operates a subscription, so cancellation terms matter more here than with per-order European services. Confirm the notice period, whether the discounted introductory rate carries a minimum term, and what happens to dispensed medication. Prescription medicines cannot be returned once dispensed.

Statutory health insurance across European markets has generally not covered medicines prescribed for weight management alone, though rules differ by country and coverage for type 2 diabetes indications follows different rules. Check your national arrangements rather than assuming.

Pros and Cons

Pros

• Clear published per-month pricing in euros
• Bundles medication with a personalised treatment plan
• Free discreet delivery included
• Team of doctors and health experts rather than a one-off prescription
• Substantial published education in local language
• Semaglutide entry pricing competitive for the European market

Cons

• Multiple published entry prices suggest promotional rates that may reset
• Subscription model requires attention to cancellation terms
• Ozempic is licensed for diabetes, not weight management — confirm your indication
• No structured behavioural curriculum or named dietitian
• Availability limited to the markets Wellis serves

Who It May Be Best For, and Limitations

Best for: Dutch- and German-speaking European patients who want medication and a treatment plan bundled into one subscription with delivery included, rather than sourcing a prescription and medication separately.

Limitations: Patients wanting per-order flexibility, video consultations, structured behavioural coaching, or the licensed weight management indication specifically.

Alternatives to Wellis

Frequently Asked Questions

How much does Wellis cost?

Wellis publishes semaglutide (Ozempic) from €149 per month, discounted from €249, and Mounjaro from €259 per month. Some published materials show entry pricing from €179 per month depending on plan. Confirm your ongoing rate before subscribing.

What is included in the Wellis subscription?

Wellis states it draws up a personal treatment plan aligned to your goals, with support from a team of doctors and health experts, and includes free discreet delivery of medication.

Which medications does Wellis offer?

Its published pricing covers semaglutide (Ozempic) and Mounjaro (tirzepatide), and its educational content covers Wegovy, Ozempic, and Mounjaro. Confirm which products are available in your country.

Is Ozempic licensed for weight loss?

No. Ozempic is licensed for type 2 diabetes; Wegovy is the semaglutide product licensed for chronic weight management. Prescribing Ozempic for weight loss is off-label, which is legal and common but affects reimbursement and supply.

Does insurance cover Wellis treatment?

Statutory health insurance across European markets has generally not covered medicines prescribed for weight management alone. Coverage rules differ by country, and diabetes indications follow different rules. Check your national arrangements.

Which countries does Wellis serve?

Wellis operates in Dutch- and German-language European markets. Confirm availability for your country before starting.

Bottom Line

Wellis brings the bundled subscription model — medication, treatment plan, and delivery in one monthly price — to European markets where the norm is separating prescription from dispensing. For patients who want simplicity, that is genuinely useful.

Strengths: clear euro pricing, bundled treatment plan and medication, free delivery, medical team support, competitive semaglutide entry pricing.

Drawbacks: multiple published entry prices suggesting promotional rates, subscription terms to check carefully, an off-label Ozempic indication to clarify, and no structured behavioural programme.

Best for: Dutch- and German-speaking patients wanting everything in one subscription.

Skip if: you want per-order flexibility or a video consultation with a doctor.

Two questions before you subscribe: what will I be charged in month three, and which product am I actually receiving — Wegovy under its licensed weight management indication, or Ozempic off-label? Both answers materially affect what you are buying.

US readers: CoreAge Rx offers all-in monthly pricing from $179–$399 including medication and provider messaging, with 12–24 hour approvals.

Medical disclaimer: Informational only, not medical advice. Semaglutide and tirzepatide products are prescription medicines with real risks and contraindications. Off-label prescribing is a clinical decision for your prescriber. Availability, pricing, and reimbursement differ by country. Consult a qualified healthcare professional before starting or changing treatment.

Sources: Wellis published pricing, programme, and Dutch-language educational pages; European Medicines Agency product information.

Date reviewed: August 2026